T1	Treatment 453 463	formoterol
T2	Treatment 493 503	salmeterol
T3	Treatment 660 799	regularly treated with salbutamol 200 micrograms twice daily during the study period, to avoid variability in beta2-adrenoceptor tolerance.
T4	Treatment 800 918	S-potassium, heart rate corrected Q-T interval (Q-Tc), and tremor score were followed as measures of systemic effects.
T5	Treatment 919 929	Formoterol
T6	Treatment 965 1034	methacholine responsiveness (4.6 doubling doses after 120 micrograms)
